rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Raman Singh

Director

Company insider

Files Form 4 as: Director, Liquidia; Director, Liquidia Technologies.

Every Form 4 they filed

In numbers

Trades disclosed
49
Buys
0
Sells
6
Bought
$0
Sold
$8.7M
Companies
2
Companies where not an officer
2
First trade
25 Jul 2018
Last trade
14 Sep 2026
Last filed
15 Sep 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
LQDA LiquidiaDirector · Biotechnology · last 14 Sep 20260 buys · 6 sells
Liquidia TechnologiesDirector · last 22 Jun 20200 buys · 0 sells

Activity over time

1 Sep 2025 – 1 Oct 2026
20Sep 25Dec 25Apr 26Jul 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
14 Sep 2026filed 15 Sep 2026LQDA Liquidiaoption or derivative · BiotechnologySEC FORM 4 Code M—8,468 at $0.00filing
14 Sep 2026filed 15 Sep 2026LQDA LiquidiaBiotechnologySEC FORM 4 Code M$79K8,468 at $9.31filing
14 Sep 2026filed 15 Sep 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$560K8,468 at $66.16filing
14 Sep 2026filed 15 Sep 2026LQDA Liquidiaoption or derivative · BiotechnologySEC FORM 4 Code M—8,468 at $0.00filing
14 Sep 2026filed 15 Sep 2026LQDA LiquidiaBiotechnologySEC FORM 4 Code M$79K8,468 at $9.31filing
14 Sep 2026filed 15 Sep 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$560K8,468 at $66.16filing
11 Sep 2026filed 15 Sep 2026LQDA LiquidiaBiotechnologySEC FORM 4 Code M$4,798556 at $8.63filing
11 Sep 2026filed 15 Sep 2026LQDA LiquidiaBiotechnologySEC FORM 4 Code M$79K8,468 at $9.31filing
11 Sep 2026filed 15 Sep 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$619K9,024 at $68.62filing
11 Sep 2026filed 15 Sep 2026LQDA Liquidiaoption or derivative · BiotechnologySEC FORM 4 Code M—556 at $0.00filing
11 Sep 2026filed 15 Sep 2026LQDA Liquidiaoption or derivative · BiotechnologySEC FORM 4 Code M—8,468 at $0.00filing
11 Sep 2026filed 15 Sep 2026LQDA Liquidiaoption or derivative · BiotechnologySEC FORM 4 Code M—556 at $0.00filing
11 Sep 2026filed 15 Sep 2026LQDA Liquidiaoption or derivative · BiotechnologySEC FORM 4 Code M—8,468 at $0.00filing
11 Sep 2026filed 15 Sep 2026LQDA LiquidiaBiotechnologySEC FORM 4 Code M$4,798556 at $8.63filing
11 Sep 2026filed 15 Sep 2026LQDA LiquidiaBiotechnologySEC FORM 4 Code M$79K8,468 at $9.31filing
11 Sep 2026filed 15 Sep 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$619K9,024 at $68.62filing
16 Jun 2026filed 18 Jun 2026LQDA LiquidiaBiotechnologySEC FORM 4 Code A—5,882 at $0.00filing
16 Jun 2026filed 18 Jun 2026LQDA LiquidiaBiotechnologySEC FORM 4 Code A—5,882 at $0.00filing
21 May 2026filed 26 May 2026LQDA LiquidiaBiotechnologySEC FORM 4 Code M$168K19,444 at $8.63filing
21 May 2026filed 26 May 2026LQDA LiquidiaBiotechnologySEC FORM 4 Code M$111K10,050 at $11.00filing

Sectors

Health Care6

Buys in green, sells in red, by the company’s sector.

Related people

Roger JeffsChief Executive Officer · Chief Executive Officer at Liquidia, filing Form 4 there in the last year
Michael KasetaCFO and COO · CFO and COO at Liquidia, filing Form 4 there in the last year
Jason AdairChief Business Officer · Chief Business Officer at Liquidia, filing Form 4 there in the last year
Scott MoomawChief Commercial Officer · Chief Commercial Officer at Liquidia, filing Form 4 there in the last year
Russell SchundlerGeneral Counsel · General Counsel at Liquidia, filing Form 4 there in the last year
Dana BoyleChief Accounting Officer · Also traded LQDA in the last 90 days
Rajeev SaggarChief Medical Officer · Also traded LQDA in the last 90 days
Sanjeev KhindriChief Development Officer · Also traded LQDA in the last 90 days